Showing results (191-200 of 645) with videos related to
Sort By:
Pageof 65
Frontiers in Psychiatry|February 2, 2019
Dynamic Patterns of Threat-Associated Gene Expression in the Amygdala and BloodAdriana Lori, Stephanie A Maddox, Sumeet Sharma, et al.Biological Psychiatry|October 8, 2013
Angiotensin type 1 receptor inhibition enhances the extinction of fear memoryPaul J Marvar, Jared Goodman, Sebastien Fuchs, et al.Biological Psychiatry|June 23, 2024
Critically Assessing the Unanswered Questions of How, Where, and When to Induce Plasticity in the Posttraumatic Stress Disorder Network With Transcranial Magnetic StimulationJoshua C Brown, Jamie Kweon, Prayushi Sharma, et al.Biological Psychiatry|July 12, 2024
Affective Visual Circuit Dysfunction in Trauma and Stress-Related DisordersNathaniel G Harnett, Leland L Fleming, Kevin J Clancy, et al.Neuroimage|December 3, 2014
A comparative analysis of mouse and human medial geniculate nucleus connectivity: a DTI and anterograde tracing studyOrion P Keifer, David A Gutman, Erin E Hecht, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 21, 2021
Prefrontal cortex, amygdala, and threat processing: implications for PTSDM Alexandra Kredlow, Robert J Fenster, Emma S Laurent, et al.Journal of Consulting and Clinical Psychology|May 2, 2012
The relation between changes in patients' interpersonal impact messages and outcome in treatment for chronic depressionMichael J Constantino, Holly B Laws, Bruce A Arnow, et al.Psychological Services|August 14, 2013
The "PE coach" smartphone application: an innovative approach to improving implementation, fidelity, and homework adherence during prolonged exposureGreg M Reger, Julia Hoffman, David Riggs, et al.Experimental and Clinical Psychopharmacology|June 26, 2018
Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) and R(-) MDMA on actigraphy-based daytime activity and sleep parameters in rhesus monkeysLaís F Berro, Hannah Shields, Melis Odabas-Geldiay, et al.Brain and Behavior|December 24, 2013
A factor analysis of posttraumatic stress disorder symptoms using data pooled from two venlafaxine extended-release clinical trialsDan J Stein, Barbara O Rothbaum, David S Baldwin, et al.Pageof 65